Research indicates that although semaglutide did not significantly improve hepatic fibrosis, it had positive effects on hepatic steatosis, weight control, and diabetes-related parameters, offering a new therapeutic direction for patients with NASH and compensated cirrhosis (Flint et al., 2021
the remaining $3 trillion flows to consumers, employers, and pharmaceutical manufacturers
10.1016/j.atherosclerosis.2017.05.006 Atherosclerosis
YounossiZMGolabiPPaikJMHenryAVan DongenCHenryL
Varney started the patient on ursodeoxycholic acid, and over the course of 6 weeks, the patients symptoms gradually improved and eventually resolved
Three-Step Solution: Slow down by reducing stress and avoiding high-histamine foods (leftovers, fermented foods, caffeine)